Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Non-medical steroid use in gym-goers is risky and needs better prevention and care strategies.

Low testosterone and SHBG levels are linked to higher COVID-19 death rates.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Testosterone reduces key molecules needed for early pregnancy in rats.

Kelulut Honey can help regulate sex hormone receptors in rats with Polycystic Ovary Syndrome, similar to common medications.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Some supplements and hormones can increase hair loss by raising DHT levels.

Men are increasingly seeking quick-result cosmetic treatments for their thicker, oilier skin and hair loss issues.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Infertile men are more likely to produce sperm with abnormal chromosome numbers, which can affect pregnancy success and embryo health.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Sex and sex hormones can affect brain inflammation in Parkinson's disease, with male mice being more affected and female mice showing a protective effect.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.